Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Crohn's Disease
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Masking Description: Only 3 arms are blinded in this study.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02914600
- Collaborators
- Galapagos NV
- Investigators
- Study Director: Gilead Study Director Gilead Sciences
Get Well Soon